We're on the lookout for entrepreneurial individuals with technical and commercial domain expertise with keen interest in founding and building a global scale, impact driven, high growth company from ground up (full-time).
The role is full-time, initially remote (can work from anywhere) with possible relocation once the new venture is incorporated.
Over 6 million individuals live with Parkinson’s today, and this number is projected to reach 12 million globally by 2040 as populations age. Whilst current therapies do offer symptomatic relief from debilitating cognitive and motor symptoms, no clinically approved drug intervenes at the root cause, meaning disease progression cannot be prevented. In addition, emerging therapeutics which show great promise in animal models often fail to translate in the clinical setting, with even the most successful clinical trials reporting incremental benefit, often capped by dose limiting toxicity.
We’re currently building an outcomes graph, working backwards from the desired high level outcome to develop curative therapeutics for Parkinson's.
PhD or equivalent industry R&D know-how focused on neuroscience or a related field;
Industry-specific know-how, commercial knowledge (e.g. strategic partnerships, clinical trials, regulations etc.) and strong network within pharma;
Experience in biotech, building and scaling new technologies from concept to demonstration;
Experience in building and scaling a high-growth enterprise (leadership/c-suite roles).
Access to optimised, purpose-built, proprietary tools, resources, and processes to help create high-impact ventures from scratch;
Opportunity area-specific know-how from our network of Partners and Advisors;
Up to £250k in investment to incorporate the new venture and develop early proof-of-concept data;
Continuous post-spinout support, including fundraising, commercial partnerships, recruitment, and team-building;
Deep Science Ventures is creating a future in which both humans and the planet can thrive.
We use our unique venture creation process to create, spin-out and invest into science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures.
We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions.
#